GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Current Deferred Revenue

J.Molner AS (OTSE:MOLNR) Current Deferred Revenue : €0.00 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

J.Molner AS's current deferred revenue for the quarter that ended in Dec. 2023 was €0.00 Mil.

J.Molner AS Current Deferred Revenue Historical Data

The historical data trend for J.Molner AS's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Current Deferred Revenue Chart

J.Molner AS Annual Data
Trend Dec21 Dec22 Dec23
Current Deferred Revenue
- - -

J.Molner AS Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Current Deferred Revenue - - - - -

J.Molner AS Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of J.Molner AS's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


J.Molner AS (OTSE:MOLNR) Business Description

Traded in Other Exchanges
N/A
Address
Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618
J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines